Background: Central serous chorioretinopathy (CSCR) is described by researchers as a condition that results from fluid under the retinal pigment epithelium, originating from the choroid of the eye. This disease usually affects the central part of vision and may resolve on its own over time, though in some cases, it can persist for long periods or recur. In our country, there is a lack of research regarding this condition, which led to the motivation for gathering and reviewing existing works on this topic. Aim: To collect and analyze a review of the studies on central serous chorioretinopathy (CSCR). Methods: We reviewed and analyzed literature related to CSCR published in electronic sources such as Thomson Reuters, PubMed-central database, and Google Scholar using literature review methods. Results: CSCR is most commonly seen in individuals aged 35-55 years, with a significantly higher prevalence in men (9.9/100,000) compared to women (1.7/100,000). Researchers found that the prevalence of CSCR is nearly the same among populations in Europe, Africa, and Asia. CSCR typically affects one eye, but it occurs in both eyes in up to 40% of cases. Weenink A (2001) studied the family members of 27 patients with bilateral CSCR, finding that 52% of family members had been diagnosed with CSCR, and 27.5% of them had chronic CSCR in at least one eye. This suggests a potential genetic predisposition to CSCR. According to researchers, while CSCR can be diagnosed clinically, additional imaging techniques like fluorescein angiography and optical coherence tomography are frequently used to rule out other diagnoses and guide treatment. Conclusion CSCR generally has a favorable prognosis, but recurrences and its effects on visual function indicate the need for effective management strategies. To maintain long-term visual improvement, it is essential to provide healthcare services tailored to the patient’s specific conditions and risk factors.